• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[骨肿瘤中的细胞增殖。Ki-67蛋白表达的免疫组织学研究]

[Cell proliferation in bone tumors. Immunohistologic study of Ki-67 protein expression].

作者信息

Stenzel I, Pösl M, Ritzel H, Hentz M, Werner M, Delling G

机构信息

Abteilung Osteopathologie, Hamburger Knochentumorregister Pathologisches Institut, Universität Hamburg.

出版信息

Pathologe. 1996 Jan;17(1):56-62. doi: 10.1007/s002920050135.

DOI:10.1007/s002920050135
PMID:8685097
Abstract

Bone tumors represent a group of tumors of various dignity. In spite of this single tumor entities may display strong morphological resemblance to each other which can in turn result in profound difficulties in differential diagnosis. The biological behaviour of a tumor is mainly determined by its rate of proliferation. In this study the rate of proliferation of 64 bone tumors (30 high-grade central osteosarcomas, 6 low-grade osteosarcomas, 8 giant cell tumors, 8 aneurysmatic bone cysts, 5 osteoidosteomas/osteoblastomas, 7 fibrous dysplasias and 5 cases of a myositis ossificans) were analysed. Immunohistochemistry was performed on paraffin-embedded tissue sections using the MIB-1 monoclonal antibody. MIB-1 recognizes the proliferation-associated Ki-67 protein which is expressed during the active phases of the cell cycle but cannot be detected in senescent cells. Among high-grade central osteosarcomas a significantly higher rate of proliferation (average value 30%) was found in comparison with low-grade osteosarcomas and other benign intraosseous bone tumors. This approach proved to be very useful in the distinction between high-grade and low-grade osteosarcomas as well as bone-forming intraosseous tumors. However distinguishing low-grade osteosarcomas from benign bone tumors by determining only the rate of proliferation was not possible, although interestingly, the proliferative rate of myositis ossificans, a purely reactive lesion, was in the range of the values determined for high-grade osteosarcoma.

摘要

骨肿瘤是一组具有不同性质的肿瘤。尽管如此,单个肿瘤实体之间可能在形态上有很强的相似性,这反过来可能导致鉴别诊断出现严重困难。肿瘤的生物学行为主要由其增殖速率决定。在本研究中,分析了64例骨肿瘤(30例高级别中央骨肉瘤、6例低级别骨肉瘤、8例骨巨细胞瘤、8例动脉瘤样骨囊肿、5例骨样骨瘤/骨母细胞瘤、7例骨纤维异常增殖症和5例骨化性肌炎)的增殖速率。使用MIB-1单克隆抗体对石蜡包埋的组织切片进行免疫组织化学检测。MIB-1识别与增殖相关的Ki-67蛋白,该蛋白在细胞周期的活跃期表达,但在衰老细胞中无法检测到。与低级别骨肉瘤和其他良性骨内肿瘤相比,在高级别中央骨肉瘤中发现增殖速率明显更高(平均值为30%)。这种方法在区分高级别和低级别骨肉瘤以及骨形成性骨内肿瘤方面被证明非常有用。然而,仅通过确定增殖速率来区分低级别骨肉瘤和良性骨肿瘤是不可能的,尽管有趣的是,作为一种纯粹反应性病变的骨化性肌炎的增殖速率处于高级别骨肉瘤所确定的值范围内。

相似文献

1
[Cell proliferation in bone tumors. Immunohistologic study of Ki-67 protein expression].[骨肿瘤中的细胞增殖。Ki-67蛋白表达的免疫组织学研究]
Pathologe. 1996 Jan;17(1):56-62. doi: 10.1007/s002920050135.
2
[DNA cytometry of solitary and aneurysmal bone cysts and low malignancy and high malignancy central osteosarcomas. Current significance within the scope of morphologic diagnosis of intraosseous cystic and osteoblastic lesions].
Pathologe. 1996 Jan;17(1):44-9.
3
Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma.低度恶性中央型骨肉瘤中p53、MDM2和H-ras基因的分子分析
Pathol Res Pract. 2004;200(6):439-45. doi: 10.1016/j.prp.2004.04.006.
4
Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.p53蛋白、增殖细胞核抗原(PCNA)和Ki-67在骨肉瘤中的表达。
J Korean Med Sci. 1995 Oct;10(5):360-7. doi: 10.3346/jkms.1995.10.5.360.
5
MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.MDM2 和 CDK4 在高级别骨肉瘤中的免疫组化共表达:与去分化亚型的相关性。
Am J Surg Pathol. 2012 Mar;36(3):423-31. doi: 10.1097/PAS.0b013e31824230d0.
6
[Pitfalls and typical false interpretations in bone tumors. From the viewpoint of long-term consultation].
Pathologe. 1996 Jan;17(1):1-5. doi: 10.1007/s002920050128.
7
P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions.P63表达作为一种区分骨巨细胞瘤与其他富含巨细胞骨病变的生物标志物。
Pathol Res Pract. 2016 Oct;212(10):876-879. doi: 10.1016/j.prp.2016.07.007. Epub 2016 Jul 14.
8
Low-grade intraosseous osteosarcoma in northern Japan: advantage of AgNOR and MIB-1 staining in differential diagnosis.
Hum Pathol. 2000 Jun;31(6):633-9. doi: 10.1053/hupa.2000.8231.
9
Clinical relevance of Ki-67 expression in bone tumors.Ki-67表达在骨肿瘤中的临床相关性。
Cancer. 1995 Feb 1;75(3):806-14. doi: 10.1002/1097-0142(19950201)75:3<806::aid-cncr2820750310>3.0.co;2-s.
10
[Osteosarcoma--apoptosis and proliferation. Study of bcl-2 expression].
Pathologe. 1994 Dec;15(6):337-44. doi: 10.1007/s002920050063.

引用本文的文献

1
p53 mutations may be involved in malignant transformation of giant cell tumor of bone through interaction with GPX1.p53 突变可能通过与 GPX1 相互作用而参与骨巨细胞瘤的恶性转化。
Virchows Arch. 2013 Jul;463(1):67-77. doi: 10.1007/s00428-013-1435-z. Epub 2013 Jun 8.
2
Immunohistochemical Estimates of Angiogenesis, Proliferative Activity, p53 Expression, and Multiple Drug Resistance Have No Prognostic Impact in Osteosarcoma: A Comparative Clinicopathological Investigation.免疫组织化学评估血管生成、增殖活性、p53表达及多药耐药性对骨肉瘤无预后影响:一项比较临床病理研究
Sarcoma. 2008;2008:874075. doi: 10.1155/2008/874075. Epub 2009 Feb 25.
3
Epiphyseal osteoblastoma-like osteosarcoma.
骨骺骨母细胞瘤样骨肉瘤
Skeletal Radiol. 2004 Jan;33(1):46-50. doi: 10.1007/s00256-003-0716-z. Epub 2003 Nov 20.